Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health monitoring in resource-limited settings news

Show

From To
European prize for HIV diagnostic kit

The device, called SAMBA, can accurately and rapidly diagnose HIV using a tiny sample of blood. The kits are used in countries with no laboratory infrastructure and they do not need to be operated by medically trained staff.

Published
12 June 2016
From
Wellcome Trust
Significant attrition at each stage of HIV care cascade in South Africa

There is significant attrition at each stage of the HIV care continuum in South Africa, according to a study published in the online edition of the Journal

Published
06 June 2016
By
Michael Carter
Very high levels of drug resistance seen in people experiencing first-line antiretroviral therapy failure in Kenya

A cross-sectional survey of viral load in patients attending the largest HIV clinic in Kenya has shown that after an average of nearly two years

Published
31 May 2016
By
Gus Cairns
Indian study proves that more people virally suppressed in a population equals fewer HIV infections

The proportion of people living with HIV in a population who have a detectable viral load is much more strongly associated with the rate of

Published
06 April 2016
By
Gus Cairns
Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day

Making point-of-care CD4 count diagnostics available, revising adherence counselling requirements and giving extra training to healthcare workers can almost quadruple the number of patients who begin antiretroviral

Published
25 February 2016
By
Roger Pebody
Abbott inks $5.8B deal for Alere to expand in point-of-care diagnostics

Abbott has landed on its next purchase, snatching up diagnostics outfit Alere to bulk up in point-of-care diagnostics and expand its international reach.

Published
09 February 2016
From
Fierce Medical Devices
HIV and drug resistance

A recent study found more resistance to the antiretroviral medicine tenofovir than had previously been reported, with 20% resistance to tenofovir in patients with treatment failure in Europe and over 50% resistance in patients with treatment failure in sub-Saharan Africa... The study underlines the importance of rapidly identifying treatment failure through routine measurement of viral load suppression—this is the basis of the third pillar of UNAIDS’ 90–90–90 treatment target, that 90% of people accessing HIV treatment have suppressed viral loads.

Published
09 February 2016
From
UNAIDS
Malawi: Govt Launches HIV Viral Load Scale Up Strategic Implementation Plan

Government on Wednesday launched the Viral Load scale Up Strategic Implementation Plan for the years 2015 to 2018.

Published
19 January 2016
From
AllAfrica
Barriers to progress – Treatment activists’ response to WHO HIV treatment guidelines 2015

Three issues that represent barriers to continued progress: community-led treatment education is inadequately supported and needs to be scaled up; people living in middle income countries are denied affordable access to essential medicines, such as dolutegravir; availability of routine viral load monitoring remains patchy.and limited in too many countries.

Published
01 December 2015
From
International Treatment Preparedness Coalition
Routine viral load tests must be accessible for all

In Zambia, on 30 October, hundreds of people marched as part of a new campaign calling on African governments to make viral load tests routinely available to all citizens living with HIV. The campaign Be Healthy – Know your viral load was launched in Lusaka, and people living with HIV, treatment advocates and representatives from the participating countries* took part in a march which was flagged off by George Nyendwa, Mayor of Lusaka.

Published
10 November 2015
From
Key Correspondents

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.